| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sohyeon Kim, Mi-Yeon Eun, Jae-Joon Lee, Hung Youl Seo. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Patients Meeting the 2017 McDonald Criteria for Multiple Sclerosis: Challenges in Diagnosis and Treatment Decisions. Annals of neurology. 2023-12-21. PMID:38087803. |
myelin oligodendrocyte glycoprotein antibody-positive patients meeting the 2017 mcdonald criteria for multiple sclerosis: challenges in diagnosis and treatment decisions. |
2023-12-21 |
2023-12-23 |
Not clear |
| Stephanie B Syc-Mazurek, John J Chen, Pearse Morris, Elia Sechi, Jaywant Mandrekar, Jan-Mendelt Tillema, A Sebastian Lopez-Chiriboga, Claudia Francesca Lucchinetti, Nicholas Zalewski, Laura Cacciaguerra, Marina Buciuc, Karl N Krecke, Steven Anthony Messina, M Tariq Bhatti, Sean J Pittock, Eoin P Flanaga. Frequency of New or Enlarging Lesions on MRI Outside of Clinical Attacks in Patients With MOG-Antibody-Associated Disease. Neurology. vol 99. issue 18. 2023-12-19. PMID:36175150. |
to determine the frequency of new or enlarging t2-hyperintense or enhancing lesions outside of clinical attacks in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) vs multiple sclerosis (ms) and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder (aqp4+nmosd). |
2023-12-19 |
2023-12-21 |
Not clear |
| Patricia A Mathieu, Yim Rodriguez Sampertegui, Fernanda Elias, Alexis Silva Silva, María de Luján Calcagno, Ricardo López, Ana M Adam. Oligodeoxynucleotide IMT504: Effects on Central Nervous System Repair Following Demyelination. Molecular neurobiology. 2023-12-08. PMID:38064102. |
multiple sclerosis (ms) is an immune-mediated central nervous system (cns) disease characterized by demyelination resulting from oligodendrocyte loss and inflammation. |
2023-12-08 |
2023-12-17 |
rat |
| Katharina Messias, Renata Moreto, Camila Aquino Cruz, Nathalia Rossoni Ronchi, Antonio Carlos Dos Santos, André Messias, Vanessa Daccach Marque. Clinical spectrum of myelin oligodendrocyte glycoprotein antibody-associated disease in Brazil: a single-center experience. Arquivos de neuro-psiquiatria. vol 81. issue 11. 2023-11-30. PMID:38035583. |
anti-myelin oligodendrocyte glycoprotein (anti-mog) antibody-associated disease (mogad) is an immune-mediated neurological disorder with a broad spectrum of clinical presentation that is often difficult to distinguish from other demyelinating diseases, such as multiple sclerosis and neuromyelitis optica spectrum disorder. |
2023-11-30 |
2023-12-10 |
Not clear |
| Danqing Qin, Chunjuan Wang, Dong Li, Shougang Gu. Exosomal miR-23a-3p derived from human umbilical cord mesenchymal stem cells promotes remyelination in central nervous system demyelinating diseases by targeting Tbr1/Wnt pathway. The Journal of biological chemistry. 2023-11-23. PMID:37995941. |
oligodendrocyte precursor cells (opcs) are present in the adult central nervous system (cns), and their impaired ability to differentiate into myelinating oligodendrocytes (ols) can lead to demyelination in patients with multiple sclerosis (ms), accompanied by neurological deficits and cognitive impairment. |
2023-11-23 |
2023-11-29 |
human |
| Negar Molazadeh, Tetsuya Akaishi, Gauruv Bose, Shuhei Nishiyama, Tanuja Chitnis, Michael Lev. Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis. Multiple sclerosis and related disorders. vol 80. 2023-11-10. PMID:37949025. |
progression independent of relapses in aquaporin4-igg-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis. |
2023-11-10 |
2023-11-20 |
Not clear |
| Negar Molazadeh, Tetsuya Akaishi, Gauruv Bose, Shuhei Nishiyama, Tanuja Chitnis, Michael Lev. Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis. Multiple sclerosis and related disorders. vol 80. 2023-11-10. PMID:37949025. |
to determine whether progression independent of relapse activity (pira) is present in aquaporin4-igg-seropositive neuromyelitis optica spectrum disorder (aqp4+nmosd), myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) and relapsing remitting multiple sclerosis (rrms). |
2023-11-10 |
2023-11-20 |
Not clear |
| Sahar Ghosouri, Mohammad Bakhtiari, Soleimani Mitra, Nazem Ghasem. Valproic acid effects on human adipose-derived stem cell differentiation into oligodendrocytes and improved remyelination in a mouse model of Multiple Sclerosis. The International journal of developmental biology. vol 67. issue 3. 2023-11-08. PMID:37937413. |
in the present study, we have assessed the effects of vpa alone or in combination with hadscs on oligodendrocyte differentiation, remyelination, and functional recovery in a mouse model of multiple sclerosis (ms). |
2023-11-08 |
2023-11-20 |
mouse |
| Shi-Hao Cui, Na Suo, Ying Yang, Xuan Wu, Shi-Meng Guo, Xin Xi. The aminosteroid U73122 promotes oligodendrocytes generation and myelin formation. Acta pharmacologica Sinica. 2023-11-07. PMID:37935896. |
ols are differentiated from oligodendrocyte precursor cells (opcs) during development and myelin repair, which is often insufficient in the latter case in demyelinating diseases such as multiple sclerosis (ms). |
2023-11-07 |
2023-11-20 |
Not clear |
| Armin Handzic, Edward Margoli. Myelin Oligodendrocyte Glycoprotein-related isolated internuclear ophthalmoplegia mimicking multiple sclerosis. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2023-11-07. PMID:37932895. |
myelin oligodendrocyte glycoprotein-related isolated internuclear ophthalmoplegia mimicking multiple sclerosis. |
2023-11-07 |
2023-11-08 |
Not clear |
| Mohanlall Narine, Maryam A Azmi, Martin Umali, Ashley Volz, Holly Colognat. The AMPK activator metformin improves recovery from demyelination by shifting oligodendrocyte bioenergetics and accelerating OPC differentiation. Frontiers in cellular neuroscience. vol 17. 2023-10-31. PMID:37904733. |
multiple sclerosis (ms) is a chronic disease characterized by immune-mediated destruction of myelinating oligodendroglia in the central nervous system. |
2023-10-31 |
2023-11-08 |
mouse |
| Victoria Tran, Nicholas Carpo, Sophia Shaka, Joile Zamudio, Sungshin Choi, Carlos Cepeda, Araceli Espinosa-Jeffre. Correction: Tran et al. Delayed Maturation of Oligodendrocyte Progenitors by Microgravity: Implications for Multiple Sclerosis and Space Flight. Life (Basel, Switzerland). vol 13. issue 10. 2023-10-30. PMID:37895487. |
delayed maturation of oligodendrocyte progenitors by microgravity: implications for multiple sclerosis and space flight. |
2023-10-30 |
2023-11-08 |
Not clear |
| Simone Sacco, Akash Virupakshaiah, Nico Papinutto, Vinicius A Schoeps, Amit Akula, Haojun Zhao, Jennifer Arona, William A Stern, Janet Chong, Janace Hart, Scott S Zamvil, Pascal Sati, Roland G Henry, Emmanuelle Wauban. Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease. Multiple sclerosis (Houndmills, Basingstoke, England). 2023-10-28. PMID:37897254. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) and pediatric-onset multiple sclerosis (poms) share clinical and magnetic resonance imaging (mri) features but differ in prognosis and management. |
2023-10-28 |
2023-11-08 |
Not clear |
| Kimberly K Hoi, Wenlong Xia, Ming Ming Wei, Maria Jose Ulloa Navas, Jose-Manuel Garcia Verdugo, Maxence V Nachury, Jeremy F Reiter, Stephen P J Fanc. Primary cilia control oligodendrocyte precursor cell proliferation in white matter injury via Hedgehog-independent CREB signaling. Cell reports. vol 42. issue 10. 2023-10-20. PMID:37858465. |
remyelination after white matter injury (wmi) often fails in diseases such as multiple sclerosis because of improper recruitment and repopulation of oligodendrocyte precursor cells (opcs) in lesions. |
2023-10-20 |
2023-11-08 |
Not clear |
| Vanesa Mattera, Federico Occhiuzzi, Jorge Correale, Juana M Pasquin. Remyelinating effect driven by transferrin-loaded extracellular vesicles. Glia. 2023-10-20. PMID:37860913. |
oligodendrocytes (ols) are myelinating glial cells developed from oligodendrocyte progenitor cells (opcs) and damaged in chronic demyelinating diseases such as multiple sclerosis (ms). |
2023-10-20 |
2023-11-08 |
mouse |
| Emilie Bergeron, Marc A Bouffar. Evidence-based management of optic neuritis. Current opinion in ophthalmology. 2023-10-17. PMID:37846574. |
optic neuritis can result from several distinct causes, including multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein antibody disease (mogad), when not idiopathic. |
2023-10-17 |
2023-11-08 |
Not clear |
| Esther Ganelin-Cohen, Shahar Shelly, Yael Schiller, Adi Vaknin-Dembinsky, Maayan Shachor, Ariel Rechtman, Michael Osherov, Nitsan Duvdevan, Ayal Rozenber. Dual positivity for anti-MOG and oligoclonal bands: Unveiling unique clinical profiles and implications. Multiple sclerosis and related disorders. vol 79. 2023-10-06. PMID:37801958. |
this complexity is further magnified in cases where patients concurrently exhibit both anti-myelin oligodendrocyte glycoprotein (anti-mog) positivity and detectable oligoclonal bands (ocbs) this retrospective study investigates the clinical and imaging attributes of dual-positive patients, those with both anti-mog positivity and ocbs, the study aims to show potential areas of overlap between multiple sclerosis (ms) and mogad. |
2023-10-06 |
2023-10-15 |
Not clear |
| Yufei Wang, Qusang Danzeng, Wencan Jiang, Bingqing Han, Xiaowen Zhu, Ziwei Liu, Jialu Sun, Kelin Chen, Guojun Zhan. A retrospective study of myelin oligodendrocyte glycoprotein antibody-associated disease from a clinical laboratory perspective. Frontiers in neurology. vol 14. 2023-09-29. PMID:37771453. |
to analyze the differences in laboratory data between patients with myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad), multiple sclerosis (ms) and neuromyelitis optica spectrum disorder (nmosd). |
2023-09-29 |
2023-10-07 |
Not clear |
| Benjamin Vlad, Ina Reichen, Stephan Neidhart, Marc Hilty, Dimitra Lekaditi, Christine Heuer, Amanda Eisele, Mario Ziegler, Markus Reindl, Andreas Lutterotti, Axel Regeniter, Ilijas Jelci. Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis. Frontiers in immunology. vol 14. 2023-09-25. PMID:37744325. |
myelin oligodendrocyte glycoprotein antibody-associated autoimmune disease (mogad) is a rare monophasic or relapsing inflammatory demyelinating disease of the central nervous system (cns) and can mimic multiple sclerosis (ms). |
2023-09-25 |
2023-10-07 |
Not clear |
| Sergey Kalinin, Douglas L Feinstei. Astrocyte lipocalin-2 modestly effects disease severity in a mouse model of multiple sclerosis while reducing mature oligodendrocyte protein and mRNA expression. Neuroscience letters. 2023-09-25. PMID:37748675. |
astrocyte lipocalin-2 modestly effects disease severity in a mouse model of multiple sclerosis while reducing mature oligodendrocyte protein and mrna expression. |
2023-09-25 |
2023-10-07 |
mouse |